Skip to main content
. 2022 Jul 24;12(2):1655–1672. doi: 10.1002/cam4.5013

FIGURE 8.

FIGURE 8

TP73‐AS1 augments migration and invasion capabilities of NSCLC cells. (A, B) Overexpression (TP73) and knockdown (siTP73‐1# and siTP73‐2#) of TP73‐AS1 promotes and suppresses migration abilities of A549 and Cula‐1 cells, respectively (* p<0.01). (C, D) Overexpression (TP73) and silencing (siTP73‐1# and siTP73‐2#) of TP73‐AS1 enhances and represses invasion abilities of A549 and Cula‐1 cells, respectively (**p<0.001). (E, F) Effects of overexpression (TP73) and silencing (siTP73‐1# and siTP73‐2#) of TP73‐AS1 on the protein expression of E‐cadherin, JunD, HLJ1, MMP2 and MMP9, as measured by western blotting. NSCLC, non‐small cell lung cancer.